Results 141 to 150 of about 147,721 (313)

Prevention and treatment of venous thromboembolism in the elderly patient [PDF]

open access: yes, 2007
Enrico Tincani1, Mark A Crowther2, Fabrizio Turrini1, Domenico Prisco31Unità Operativa di Medicina Interna Cardiovascolare, Nuovo Ospedale Civile di Modena S.Agostino-Estense, Modena, Italy; 2McMaster University, St.
Enrico Tincani   +3 more
core  

Tracheostomy vs. Delayed Extubation in Head and Neck Reconstruction: A Meta‐Analysis

open access: yesThe Laryngoscope, EarlyView.
High volume centers are trialing delayed extubation as an alternative management approach to tracheostomy in patients undergoing head and neck reconstruction (HNR). This systematic review shows that patients in the delayed extubation group are four times less likely to suffer an airway complication (p = 0.295) and eight times less likely to suffer a ...
Sahil Goel   +6 more
wiley   +1 more source

Elevated BMI Is Not Associated With Adverse Outcomes in Open Airway Reconstruction

open access: yesThe Laryngoscope, EarlyView.
ABSTRACT Background Open airway reconstruction is indicated for structural airway stenoses but may be associated with significant morbidity. While obesity influences perioperative outcomes in many surgical domains, its role in airway reconstruction remains unclear.
Dylan Bertoni   +3 more
wiley   +1 more source

Preoperative Anemia and Perioperative Outcomes in Children: Prevalence, Risk Factors, and Associations in an Australian Cohort

open access: yesPediatric Anesthesia, EarlyView.
ABSTRACT Aims Preoperative anemia is a potentially modifiable risk factor in children undergoing surgery, but contemporary data describing its prevalence and associated outcomes in high‐income settings are limited. We aimed to determine the prevalence of anemia in a pediatric major‐surgery surgical cohort, identify associated demographic and clinical ...
Matthew Hart   +2 more
wiley   +1 more source

Sickle Cell Disease: Historical Overview and Current Therapies

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide, yet the limited treatment options currently available do not always adequately control the disease and carry significant side effects. At present, the only curative treatment is hematopoietic stem cell (HSC) transplantation, a procedure that carries considerable challenges and numerous ...
Oluwaseun O. Babatunde   +4 more
wiley   +1 more source

New anticoagulants for the prevention of venous thromboembolism [PDF]

open access: yes, 2010
Cecilia Becattini, Alessandra Lignani, Giancarlo AgnelliInternal and Cardiovascular Medicine and Stroke Unit, University of Perugia, ItalyAbstract: Anticoagulant drugs have an essential role in the prevention and treatment of thromboembolic diseases ...
Giancarlo Agnelli   +2 more
core  

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

open access: yesPhytotherapy Research, EarlyView.
An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia   +1 more
wiley   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

open access: yesVIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation

open access: yesTherapeutics and Clinical Risk Management, 2018
Nobuhiro Kanaji,1 Hitoshi Mizoguchi,1 Takuya Inoue,1 Akira Tadokoro,2 Naoki Watanabe,1 Tomoya Ishii,1 Yasunori Tojo,2 Masahiro Yamaguchi,3 Norimitsu Kadowaki1 1Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory ...
Kanaji N   +8 more
doaj  

Home - About - Disclaimer - Privacy